In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Drug:  pegaspargase
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 1952, CCG-1952, CDR0000064665, NCT00002744

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: MRC-LEUK-ALL97, EU-97032, NCT00003437

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 9904, COG-P9904, POG-9904, CDR0000067657, NCI-2012-02321, NCT00005585

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: 9905, COG-P9905, POG-9905, CDR0000067704, NCI-2012-02325, NCT00005596

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 1991, CCG-1991, CDR0000067855, NCI-2012-02333, U10CA98543, COG-C1991, NCT00005945

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9006

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: DFCI-91001, NCI-T91-0059D, T91-0059

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI
Protocol IDs: POG-9295

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 years
Sponsor: NCI
Protocol IDs: POG-9202

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9203

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 31
Sponsor: NCI, Other
Protocol IDs: AALL0232, COG-AALL0232, CDR0000349182, NCT00075725

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 10
Sponsor: NCI, Other
Protocol IDs: AALL0331, COG-AALL0331, CDR0000409589, NCT00103285

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, NCI-2009-00306, COG-AALL0433, CDR0000495359, U10CA098543, NCT00381680

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: 05-001 / CDR0000513019, P01CA068484, P30CA006516, DFCI-05001, NCT00400946

20.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCI-2010-01997, NCT00452439

21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2009-00312, CDR0000600217, COG-AALL0622, AALL0622, U10CA098543, NCT00720109

22.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Unknown
Age: 25 to 65
Sponsor: Other
Protocol IDs: UCL-08-0167, UCL/08/0167, EU-21009, EUDRACT-2009-012717-22, UCL-UKALL14, MREC-09-H0711-90, NCRI-UCL-08-0167, CRUK-C27995-A9609, NCT01085617

24.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Closed
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, CDR0000514500, COG-AALL0434, AALL0434, U10CA098543, NCT00408005

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 1 to 21
Sponsor: NCI
Protocol IDs: POG-9061
1    
New Search